Abstract:Kasper Fjellhaugen Hjuler, 1, 2 Louise Faurskov Møller, 2, 3 Cathrine Dawn Büttner Elgaard, 2, 3 Laura Gaïni, 4 Lars Iversen, 2, 3 Tirill Fjellhaugen Hjuler 5 1 Department of Dermatology, Aalborg University Hospital, Aalborg, Denmark; 2 Danish National Centre for Autoimmune Diseases, Aarhus University Hospital, Aarhus, Denmark; 3 Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark; 4 Institute of Psychology, Aarhus University, Aarhus, Denmark; 5 Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Aarhus, Denmark Correspondence: Kasper Fjellhaugen Hjuler, Department of Dermatology, Aalborg University Hospital, Mølleparkvej 4, Aalborg, DK-9000, Denmark, Tel +4531244813, Email Purpose: Immune-mediated inflammatory diseases (eg, axial spondylitis, psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and hidradenitis suppurativa) are common diseases that exert an extensive effect on the health-related quality of life, particularly when multiple concomitant conditions are present. Previous reports indicate that the traditional siloed approach to care can lead to a lack of patient centricity and inefficient disease management. In this article, we aimed to evaluate an interdisciplinary program for the treatment of immune-mediated inflammatory diseases compared to routine clinical practice. Patients and Methods: This was a mixed-method study, combining qualitative and quantitative data. Patients with co-occurrence of ≥ 2 immune-mediated inflammatory diseases treated in an interdisciplinary clinic (n = 48) or traditional usual care (n = 17) answered open-ended questions about their care experiences. Two independent coders blinded to patients' treatment group coded three aspects of the narratives provided by the patients' responses: Themes, Emotional valence , and Personal growth (ie, redemption) . Themes were analyzed descriptively to explore possible differences between patients assigned to the interdisciplinary clinic and patients assigned to the usual care setting. Group differences in patients' emotional experiences were assessed, and we examined potential group differences in positive personal growth. Results: Our findings indicate that an interdisciplinary combined clinic approach provides benefits for patients with multiple inflammatory diseases towards the usual setup. Patients experienced benefits on a number of specific quality-of-life themes including acceptance, optimism, disease understanding, personal growth, and better disease control. The narratives of the patients in the interdisciplinary group were significantly more emotionally positive and included more positive personal growth compared to the usual care group. Conclusion: The findings indicate a patient-reported benefit, especially from the holistic approach and cross-specialty combined consultations in an interdisciplinary clinic compared to usual specialized healthcare, which was underscored by narratives highlighting an overall improved quality of life. Keywords: patient-centered healthcare, interdisciplinary care, psoriasis, psoriatic arthritis, axial spondylitis, inflammatory bowel disease, hidradenitis suppurativa The immune-mediated inflammatory diseases (IMIDs) are a group of chronic conditions that involve dysregulation of the immune system and cause inflammation in different organs. IMIDs encompass a broad range of diseases, including axial spondylitis, psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and hidradenitis suppurativa. Such conditions affect up to approximately 7% of the Western population. 1 IMIDs, although not generally regarded as life-threatening illnesses, can cause substantial repercussions for patients, their relatives, and society as a whole, especially when patients have several concomitant conditions. These conditions can significantly affect the health-related quality of life (HRQoL) of patients and their family members, resulting in a significant impact on their lives. Patients with IMIDs may experience a number of disease-specific symptoms such as chronic pain, fatigue, physical limitations, itch, and reduced mobility, leading directly to impairment of HRQoL. 2–4 Moreover, IMIDs can cause depression, anxiety, and social isolation, further exacerbating the negative impact on HRQoL. 5–7 IMIDs may also have a significant socioeconomic impact: Patients with IMIDs often require frequent medical appointments, medications, specialized testing, and sometimes hospitalization, leading to increased healthcare utilization and costs. Moreover, IMIDs can cause disability -Abstract Truncated-

Severe Multiple Drug Intolerance Syndrome in Fibromyalgia and Irritable Bowel Syndrome

Tu2066 Prevalence of Irritable Bowel Syndrome in China: Joint Effects of Psychiatric Morbidity with Life Event Stress and Lactose Intake

Lactose Intolerance In Irritable Bowel Syndrome Patients With Diarrhoea: The Roles Of Anxiety, Activation Of The Innate Mucosal Immune System And Visceral Sensitivity

Multiple drug intolerance syndrome and multiple drug allergy syndrome: Epidemiology and associations with anxiety and depression

PWE-131 Fodmap Intake and the Risk of Irritable Bowel Syndrome in the Community: a Prospective Study

Prevalence of extra‐intestinal symptoms according to irritable bowel syndrome subtype

Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis

International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit

Polypharmacy in Patients With Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series

P367 Are patients with Inflammatory Bowel Disease and two or more associated Immune-Mediated Inflammatory Diseases different from those with no or one associated disease?

Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center

Toward characterization and definition of fibromyalgia severity

Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

Results from a Large Retrospective Observational Study

Multiple sclerosis and inflammatory bowel disease: A systematic review and meta‐analysis

Investigating the Disparities Among Drug Categories in Drug-Induced Dermatomyositis: A Systematic Review

Adapted Low-FODMAP Diet in IBS Patients with and without Fibromyalgia: Long-Term Adherence and Outcomes

A265 TEMPORAL DYNAMICS OF SYMPTOMS AND GUT MICROBIOTA IN EPISODES OF IRRITABLE BOWEL SYNDROME

Association between Drug Use and Perception of Mental Health in Women Diagnosed with Fibromyalgia: An Observational Study

On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients' Personal Experiences and Perspectives

A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome